Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS (2006) J Clin Oncol 24: 476-83 Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data. Hadley J, Yabroff KR, Barrett MJ, Penson DF, Saigal CS, Potosky AL (2010) J Natl Cancer Inst 102: 1780-93 Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP (2010) J Natl Cancer Inst 102: 1083-95 Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, Friedman D, Strong LC, Hammond S, Neglia JP, Meadows AT, Robison L, Diller L (2007) J Natl Cancer Inst 99: 300-8 Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ (2002) J Natl Cancer Inst 94: 981-90 Burden of gastrointestinal disease in the United States: 2012 update. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, Ringel Y, Kim HP, DiBonaventura MD, Carroll CF, Allen JK, Cook SF, Sandler RS, Kappelman MD, Shaheen NJ (2012) Gastroenterology 143: 1179-1187.e3 Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study. Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, Sama A, Xing J, Yang H (2016) Gastroenterology 150: 1135-1146 Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W (2006) Cancer 106: 1276-85 The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database. Cates JMM (2018) J Natl Compr Canc Netw 16: 144-152 A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Yasui Y, Liu Y, Neglia JP, Friedman DL, Bhatia S, Meadows AT, Diller LR, Mertens AC, Whitton J, Robison LL (2003) Am J Epidemiol 158: 1108-13 Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992-2002. Sun LM, Epplein M, Li CI, Vaughan TL, Weiss NS (2005) Am J Epidemiol 162: 1174-8 Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer. Zeliadt SB, Potosky AL, Penson DF, Etzioni R (2006) Int J Radiat Oncol Biol Phys 66: 395-402 Thyroid cancer: is the incidence still increasing? Hodgson NC, Button J, Solorzano CC (2004) Ann Surg Oncol 11: 1093-7 Performance Analysis of the American Joint Committee on Cancer 8th Edition Staging System for Retroperitoneal Sarcoma and Development of a New Staging Algorithm for Sarcoma-Specific Survival. Cates JMM (2017) Ann Surg Oncol 24: 3880-3887 Incidence of additional primary malignancies in patients with pancreatic and gastrointestinal neuroendocrine tumors. Kauffmann RM, Wang L, Phillips S, Idrees K, Merchant NB, Parikh AA (2014) Ann Surg Oncol 21: 3422-8 Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer. Castaldo ET, Parikh AA, Pinson CW, Feurer ID, Merchant NB (2009) Arch Surg 144: 129-34; discussion 134-5 Volume outcomes of cystectomy--is it the surgeon or the setting? Morgan TM, Barocas DA, Keegan KA, Cookson MS, Chang SS, Ni S, Clark PE, Smith JA, Penson DF (2012) J Urol 188: 2139-44 Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project. Huang GJ, Hamilton AS, Lo M, Stein JP, Penson DF (2008) J Urol 180: 520-4; discussion 524 Capsule commentary on Shahinian et al.: Patterns of bone mineral density testing in men receiving androgen deprivation for prostate cancer. Penson DF (2013) J Gen Intern Med 28: 1494 Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case-control study in Hawaii. Epplein M, Nomura AM, Hankin JH, Blaser MJ, Perez-Perez G, Stemmermann GN, Wilkens LR, Kolonel LN (2008) Cancer Causes Control 19: 869-77 Quantifying the role of PSA screening in the US prostate cancer mortality decline. Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, DiTommaso D, Karnofski K, Gulati R, Penson DF, Feuer E (2008) Cancer Causes Control 19: 175-81 Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study. Thong MS, van de Poll-Franse L, Hoffman RM, Albertsen PC, Hamilton AS, Stanford JL, Penson DF (2011) BJU Int 107: 1223-31 Trends in the treatment of localized prostate cancer using supplemented cancer registry data. Hamilton AS, Albertsen PC, Johnson TK, Hoffman R, Morrell D, Deapen D, Penson DF (2011) BJU Int 107: 576-84 Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Lipworth L, McLaughlin JK, Tarone RE, Blot WJ (2011) Eur J Cancer Prev 20: 331-3 Simple staging system for osteosarcoma performs equivalently to the AJCC and MSTS systems. Cates JMM (2018) J Orthop Res 36: 2802-2808 Trends in the use of postoperative radiation therapy in patients with localized resectable pancreatic cancer. Shinohara ET, Mitra N, Fei W, Kirschner AN, Metz JM (2012) Am J Clin Oncol 35: 543-8 Racial Disparities in Extremity Soft-Tissue Sarcoma Outcomes: A Nationwide Analysis. Alamanda VK, Song Y, Schwartz HS, Holt GE (2015) Am J Clin Oncol 38: 595-9 Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF (2004) Urology 64: 1171-6 Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy. Parikh AA, Ni S, Koyama T, Pawlik TM, Penson D (2013) J Gastrointest Surg 17: 1938-46 Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research. Bekelman JE, Handorf EA, Guzzo T, Evan Pollack C, Christodouleas J, Resnick MJ, Swisher-McClure S, Vaughn D, Ten Have T, Polsky D, Mitra N (2013) Value Health 16: 610-8 Race disparities in Wilms tumor incidence and biology. Axt J, Murphy AJ, Seeley EH, Martin CA, Taylor C, Pierce J, Caprioli RM, Whiteside M, Lovvorn HN (2011) J Surg Res 170: 112-9 Treatment approach and outcomes of vaginal melanoma. Kirschner AN, Kidd EA, Dewees T, Perkins SM (2013) Int J Gynecol Cancer 23: 1484-9 Epidemiology of vocal fold paralyses after total thyroidectomy for well-differentiated thyroid cancer in a Medicare population. Francis DO, Pearce EC, Ni S, Garrett CG, Penson DF (2014) Otolaryngol Head Neck Surg 150: 548-57
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.